REVISION OF MULTIPLE SCLEROSIS CASES ACCORDING TO NEW 2017 MCDONALD CRITERIA AMONG DIAGNOSED PATIENTS IN SULAIMANI CITY

Authors

  • Rzgar Hamid Abdula Department of Neurology of Shar Teaching Hospital, Sulaimani, Kurdistan Region, Iraq.
  • Mohammed Tahir Kurmanji Department of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
  • Zana A. Mohammed Department of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
  • Sarwer Jamal Al-Bajalan Department of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.17656/jsmc.10317

Keywords:

Multiple sclerosis, 2017 McDonald criteria, Misdiagnosis, Clinically isolated syndrome, Relapse-remitting MS

Abstract

Background 

Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disorder of the central nervous system. The diagnosis of Multiple sclerosis is challenging, owing to having a comprehensive list of differentials and mimickers.

Objectives 

To determine the frequency of misdiagnosed Multiple Sclerosis cases diagnosed among those patients in Sulaimani city.

Patients and and Methods

This retrospective observational study was conducted within a period between December 24th. 2019 and June 10th, 2020, on 106 already diagnosed patients. The study included patients diagnosed with the relapse-remitting form of multiple sclerosis. We excluded those patients with progressive forms of multiple sclerosis. We re-evaluated each patient in-depth and stratified the cases according to the diagnosis certainty based on the fulfillment of the 2017 McDonald Criteria. Finally, we returned those suspicious cases to the multiple sclerosis committee of Shar hospital to verify their final diagnosis. 

Results

Sixteen (16.9%) out of 106 patients, there was diagnostic uncertainty in which 6 (5.7%) of them received the confirmatory diagnosis of relapse-remitting multiple sclerosis by the committee, and 1(0.9%) patient considered secondary progressive multiple sclerosis. In the remaining 9 (8.4%) patients, we found the clinically isolated syndrome in 5 (4.7%) patients, solitary sclerosis in 1 (0.9%) patient, stroke with polycythemia rubra vera (PRV) in 1 (0.9%) patient, possible cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in 1 (0.9%) patient, and 1 (0.9 %) patient was undiagnosed. 

Conclusion

To sum up, the frequency of multiple sclerosis misdiagnosis was 8.4% in Sulaimani city, slightly lower than the other reporting centers.

References

Yamasaki R, Kira J-I. Multiple sclerosis. Adv Exp Med Biol. 2019;1190:217–47. DOI: https://doi.org/10.1007/978-981-32-9636-7_14

Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol (Paris). 2016;172(1):3–13. DOI: https://doi.org/10.1016/j.neurol.2015.10.006

Roostaei T, De Jager PL. Epidemiology and Genetics BT - Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders. First edition. Rizvi SA, Cahill JF, Coyle PK, editors. Cham: Springer International Publishing; 2020. 71–87 p. DOI: https://doi.org/10.1007/978-3-030-24436-1_4

Gross R, Lublin F. Multiple Sclerosis: An Overview. In: Handbook of Relapsing-Remitting Multiple Sclerosis. First edition. Cham: Springer International Publishing; 2017. p. 1–16. DOI: https://doi.org/10.1007/978-3-319-40628-2_1

Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, et al. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study. Neurology. 2019;92(22):e2527–37. DOI: https://doi.org/10.1212/WNL.0000000000007573

Sospedra M, Martin R. Immunology of multiple sclerosis. Semin Neurol. 2016;36(2):115–27. DOI: https://doi.org/10.1055/s-0036-1579739

Amezcua L, McCauley JL. Race and ethnicity on MS presentation and disease course. Mult Scler. 2020;26(5):561–7. DOI: https://doi.org/10.1177/1352458519887328

Ben-Zacharia AB, Mathewson G. Symptom Management in Multiple Sclerosis. In: Handbook of Relapsing-Remitting Multiple Sclerosis. First edition. Cham: Springer International Publishing; 2017. p. 115–34. DOI: https://doi.org/10.1007/978-3-319-40628-2_6

Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: Does it have the same features encountered in Western countries? J Neurol Sci. 2005; 234(1):67–71. DOI: https://doi.org/10.1016/j.jns.2005.03.033

Rae-Grant AD. Unusual symptoms and syndromes in multiple sclerosis. Continuum (Minneap Minn). 2013;19:992–1006. DOI: https://doi.org/10.1212/01.CON.0000433287.30715.07

Rae-Grant AD. Author response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2019; 93(17):765. DOI: https://doi.org/10.1212/WNL.0000000000008376

Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378(2):169–80. DOI: https://doi.org/10.1056/NEJMra1401483

Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502(7471):327–32. DOI: https://doi.org/10.1038/nature12647

Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336–46. DOI: https://doi.org/10.1016/S0140-6736(16)30959-X

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. DOI: https://doi.org/10.1016/S1474-4422(17)30470-2

Hardmeier M, Leocani L, Fuhr P. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS. Mult Scler. 2017;23(10):1309–19. DOI: https://doi.org/10.1177/1352458517707265

Nourbakhsh B, Mowry EM. Multiple Sclerosis Risk Factors and Pathogenesis. Contin Lifelong Learn Neurol. 2019; 25(3):596–610. DOI: https://doi.org/10.1212/CON.0000000000000725

McNicholas N, Hutchinson M, McGuigan C, Chataway J. 2017 McDonald diagnostic criteria: A review of the evidence. Mult Scler Relat Disord. 2018;24:48–54. DOI: https://doi.org/10.1016/j.msard.2018.05.011

Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. 2019;92(1):26–33.

Hurwitz BJ. The diagnosis of multiple sclerosis and the clinical subtypes. Ann Indian Acad Neurol. 2009; 12(4):226–30. DOI: https://doi.org/10.4103/0972-2327.58276

Solomon AJ. Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis. Contin Lifelong Learn Neurol. 2019; 25(3):611–35.

Filippi M, Rocca MA. Conventional MRI in multiple sclerosis. J Neuroimaging. 2007;17 Suppl 1:3S-9S. DOI: https://doi.org/10.1111/j.1552-6569.2007.00129.x

Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis. Impact 2017 McDonald criteria Clin Pract. 2019; 92(1):26–33. DOI: https://doi.org/10.1212/WNL.0000000000006583

Solomon AJ. Diagnosis, differential diagnosis, and misdiagnosis of multiple sclerosis. Continuum (Minneap Minn). 2019;25(3):611–35. DOI: https://doi.org/10.1212/CON.0000000000000728

Solomon AJ, Klein EP, Bourdette D. “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012;78(24):1986–91. DOI: https://doi.org/10.1212/WNL.0b013e318259e1b2

McDonald I, Compston A. The symptoms and signs of multiple sclerosis. In: McAlpine's Multiple Sclerosis. Fourth edition. Elsevier; 2006. p. 287–346. DOI: https://doi.org/10.1016/B978-0-443-07271-0.50008-2

Arevalo O, Riascos R, Rabiei P, Kamali A, Nelson F. Standardizing Magnetic Resonance Imaging Protocols, Requisitions, and Reports in Multiple Sclerosis: An Update for Radiologist Based on 2017 Magnetic Resonance Imaging in Multiple Sclerosis and 2018 Consortium of Multiple Sclerosis Centers Consensus Guide. J Comput Assist Tomogr. 2019; 43(1):1–12. DOI: https://doi.org/10.1097/RCT.0000000000000767

Dekker I, Wattjes MP. Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants. Neuroimaging Clin N Am. 2017; 27(2):205–27. DOI: https://doi.org/10.1016/j.nic.2016.12.002

Ömerhoca, S., Akkaş, S. Y., & İçen, N. K. (2018). Multiple Sclerosis: Diagnosis and Differential Diagnosis. Noro psikiyatri arsivi, 55(Suppl 1), S1–S9. DOI: https://doi.org/10.29399/npa.23418

Brownlee WJ. Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail? Neurology. 2019;92(1):15–6. DOI: https://doi.org/10.1212/WNL.0000000000006584

erraro D, On behalf of the RIREMS group (Rising Italian Researchers in Multiple Sclerosis), Franciotta D, Bedin R, Solaro C, Cocco E, et al. A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band. J Neurol. 2017;264(5):973–8. DOI: https://doi.org/10.1007/s00415-017-8480-5

Published

2021-09-21

How to Cite

1.
Abdula R, Kurmanji M, Mohammed Z, Al-Bajalan S. REVISION OF MULTIPLE SCLEROSIS CASES ACCORDING TO NEW 2017 MCDONALD CRITERIA AMONG DIAGNOSED PATIENTS IN SULAIMANI CITY. JSMC [Internet]. 2021 Sep. 21 [cited 2024 May 28];11(3):323-3. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10317

Similar Articles

1-10 of 113

You may also start an advanced similarity search for this article.